China Universal Asset Management »

Sutro Biopharma shares owned by China Universal Asset Management

Quarter-by-quarter ownership of Sutro Biopharma (STRO) shares owned by China Universal Asset Management from 13F filings

Historical chart of China Universal Asset Management investment in Sutro Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Sutro Biopharma held by China Universal Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sutro Biopharma by China Universal Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $13k 15k 0.87
2025-06-30 $12k 17k 0.71
2025-03-31 $11k 17k 0.65
2024-12-31 $32k 18k 1.84
2023-09-30 $5.4k 1.5k 3.47
2023-06-30 $3.7k 792 4.65
2023-03-31 $3.6k 779 4.62
2022-12-31 $4.7k 583 8.08
2022-09-30 $3.0k 488 6.15

More positions owned by China Universal Asset Management

Nvidia Corp Common Stock (NVDA)
Microsoft Corp Common Stock (MSFT)
Apple Common Stock (AAPL)
Alphabet Inc-cl A Common Stock (GOOGL)
Amazon.com Common Stock (AMZN)
Broadcom Common Stock (AVGO)
Meta Platforms Inc-class A Common Stock (META)
Tesla Common Stock (TSLA)
Amgen Common Stock (AMGN)
Alphabet Inc-cl C Common Stock (GOOG)
Vertex Pharmaceuticals Common Stock (VRTX)
Gilead Sciences Common Stock (GILD)
Proshares Ultra Gold Etp (UGL)
Netflix Common Stock (NFLX)
Spdr Gold Minishares Trust Etp (GLDM)

View all positions for China Universal Asset Management

Top funds holding Sutro Biopharma

Suvretta Capital Management
Kynam Capital Management
Millennium Management
Acadian Asset Management
Velan Capital Investment Management
Tang Capital Management
Merck & Co
Vestal Point Capital
Eversept Partners
Samsara BioCapital
Adage Capital Partners GP
BlackRock
Renaissance Technologies
Geode Capital Management
Affinity Asset Advisors

View all funds holding Sutro Biopharma